|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun Y, Wang L, Guo SC, Wu XB and Xu XH:
High-throughput sequencing to identify miRNA biomarkers in
colorectal cancer patients. Oncol Lett. 8:711–713. 2014.PubMed/NCBI
|
|
5
|
Cheng J, Deng R, Zhang P, Wu C, Wu K, Shi
L, Liu X, Bai J, Deng M, Shuai X, et al: miR-219-5p plays a tumor
suppressive role in colon cancer by targeting oncogene Sall4. Oncol
Rep. 34:1923–1932. 2015.PubMed/NCBI
|
|
6
|
Huang C, Cai Z, Huang M, Mao C, Zhang Q,
Lin Y, Zhang X, Tang B, Chen Y, Wang X, et al: miR-219-5p modulates
cell growth of papillary thyroid carcinoma by targeting estrogen
receptor α. J Clin Endocrinol Metab. 100:E204–E213. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang N, Lin J, Ruan J, Su N, Qing R, Liu
F, He B, Lv C, Zheng D and Luo R: MiR-219-5p inhibits
hepatocellular carcinoma cell proliferation by targeting
glypican-3. FEBS Lett. 586:884–891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lecocq R, Lamy F and Dumont JE: Pattern of
protein phosphorylation in intact stimulated cells: Thyrotropin and
dog thyroid. Eur J Biochem. 102:147–152. 1980. View Article : Google Scholar
|
|
9
|
Clément S, Dumont JE and Schurmans S: Loss
of calcyphosine gene expression in mouse and other rodents. Biochem
Biophys Res Commun. 232:407–413. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lefort A, Lecocq R, Libert F, Lamy F,
Swillens S, Vassart G and Dumont JE: Cloning and sequencing of a
calcium-binding protein regulated by cyclic AMP in the thyroid.
Embo J. 8:111–116. 1989.PubMed/NCBI
|
|
11
|
Nemoto Y, Ikeda J, Katoh K, Koshimoto H,
Yoshihara Y and Mori K: R2D5 antigen: A calcium-binding
phosphoprotein predominantly expressed in olfactory receptor
neurons. J Cell Biol. 123:963–976. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong H, Li X, Lou Z, Xu X, Su D, Zhou X,
Zhou W, Bartlam M and Rao Z: Crystal-structure and biochemical
characterization of recombinant human calcyphosine delineates a
novel EF-hand-containing protein family. J Mol Biol. 383:455–464.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Y, Yin L, Jing H and Zhang H:
MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1
in glioblastoma. Tumour Biol. 36:8943–8951. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sen R, Ghosal S, Das S, Balti S and
Chakrabarti J: Competing endogenous RNA: The key to
posttranscriptional regulation. ScientificWorldJournal.
2014:8962062014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs-the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Esquela-kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma Y, Zhang P, Wang F, Zhang H, Yang J,
Peng J, Liu W and Qin H: miR-150 as a potential biomarker
associated with prognosis and therapeutic outcome in colorectal
cancer. Gut. 61:1447–1453. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schee K and Ø and Flatmark K Fodstad:
MicroRNAs as biomarkers in colorectal cancer. Am J Pathol.
177:1592–1599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan
FK, Sung JJ and Yu J: MicroRNA-218 inhibits cell cycle progression
and promotes apoptosis in colon cancer by downregulating BMI1
polycomb ring finger oncogene. Mol Med. 18:1491–1498.
2013.PubMed/NCBI
|
|
22
|
Kretsinger RH: Crystallographic studies of
calmodulin and homologs. Ann N Y Acad Sci. 356:14–19. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Bont JM, de Boer ML, Kros JM, Passier
MM, Reddingius RE, Smitt PA, Luider TM and Pieters R:
Identification of novel biomarkers in pediatric primitive
neuroectodermal tumors and ependymomas by proteome-wide analysis. J
Neuropathol Exp Neurol. 66:505–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pastor MD, Nogal A, Molina-Pinelo S,
Meléndez R, Salinas A, De la Peña M González, Martín-Juan J, Corral
J, García-Carbonero R, Carnero A and Paz-Ares L: Identification of
proteomic signatures associated with lung cancer and COPD. J
Proteomics. 89:227–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Partheen K, Levan K, Osterberg L and
Horvath G: Expression analysis of stage III serous ovarian
adenocarcinoma distinguishes a sub-group of survivors. Eur J
Cancer. 42:2846–2854. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Z, Min W, Huang C, Bai S, Tang M and
Zhao X: Proteomics-based approach identified differentially
expressed proteins with potential roles in endometrial carcinoma.
Int J Gynecol Cancer. 20:9–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
